 and tests are ready should bird flu start spreading among humans in the U.S. As NPR's Will Stone reports, the Centers for Disease Control and Prevention says the risk to the general public remains low. COVID vaccine maker Moderna is receiving about $176 million from the federal government to develop an mRNA-based influenza vaccine that could be deployed against bird flu.